UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of November 2017

--------------

 

Commission File Number: 001-34563

----------

 

CONCORD MEDICAL SERVICES HOLDINGS LIMITED

--------------

18/F, Tower A, Global Trade Center

36 North Third Ring Road East, Dongcheng District

Beijing 100013

People’s Republic of China

(Address of principal executive office)

--------------

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x     Form 40-F ¨

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ________

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ________

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

 

	CONCORD MEDICAL SERVICES HOLDINGS LIMITED
	By:	/s/ Jianyu Yang
	Name:	Jianyu Yang
	Title:	Chairman and Chief Executive Officer

 

 

Date: November 28, 2017

 

 

Exhibit Index

 

 

Exhibit No.	Description
99.1	Press Release
99.2	Notice of Annual General Meeting
99.3	Shareholder Proxy

 

Exhibit 99.1

 

Concord Medical Schedules 2017 Annual Meeting of Shareholders

 

BEIJING, November 16, 2017 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it will hold its 2017 annual general meeting of shareholders on December 21, 2017, at 10:00 a.m. (Beijing Time). The meeting will be held at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, China. All shareholders of record as of the close of business on November 20, 2017 will be entitled to attend and vote. The following resolutions are to be considered and passed as ordinary resolutions, if thought fit, at the meeting:

 

1. The appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ended December 31, 2016 at a fee agreed by the directors be and is hereby ratified, confirmed and approved in all respects;

 

2. The appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2017 at a fee agreed by the directors be and is hereby approved;

 

3. The financial statements for the fiscal year ended December 31, 2016 contained in the Company's 2016 annual report be and is hereby ratified, confirmed, approved and adopted in all respects;

 

4. Consider any other business as may properly come before the annual general meeting or any adjournment thereof.

 

A copy of the notice of 2017 annual general meeting is available on the Company's investor relations website at http://ir.concordmedical.com.

 

The Company has filed its annual report on Form 20-F for the fiscal year ended December 31, 2016 with the Securities and Exchange Commission ("SEC") on May 1, 2017. The annual report can be accessed on the Company's investor relations website at http://ir.concordmedical.com as well as the SEC's website at http://www.sec.gov. Shareholders may receive a hard copy of the annual report free of charge upon request. Requests should be submitted to http://ir.concordmedical.com.

 

 

About Concord Medical

 

Concord Medical Services Holdings Limited is a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China. As of June 30, 2017, the Company operated a network of 60 centers with 41 hospital partners that spanned 34 cities and 19 provinces and administrative regions in China. Under long-term arrangements with top-tier hospitals in China, the Company provides radiotherapy and diagnostic imaging equipment and manages the daily operations of these centers, which are located on the premises of its hospital partners. The Company also provides ongoing training to doctors and other medical professionals in its network of centers to ensure a high level of clinical care for patients. For more information, please see http://ir.concordmedical.com.

 

 

For more information, please contact:

 

Concord Medical Services

Ms. Carol TIAN (Chinese and English)

+86 10 5903 6688 (ext. 608)

yuan.tian@ccm.cn

 

Exhibit 99.2

 

 

Concord Medical Services Holdings Limited

(the "Company")

 

NOTICE OF Annual GENERAL MEETING

NOTICE is hereby given that an Annual General Meeting of the Company will be held on December 21, 2017 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China at 10:00 AM (Beijing time) for the purposes of considering and, if thought fit, passing the following ordinary resolutions:

 

(i)

"THAT the appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ended December 31, 2016 at a fee agreed by the directors be and is hereby ratified, confirmed and approved in all respects;"

 

(ii)

"THAT the appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2017 at a fee agreed by the directors be and is hereby approved;"

 

(iii)

"THAT the financial statements for the fiscal year ended December 31, 2016 contained in the Company’s 2016 annual report be and is hereby ratified, confirmed, approved and adopted in all respects;"

 

(iv)

To consider any other business as may properly come before the annual general meeting or any adjournment thereof.

 

The Board of Directors of the Company has fixed the close of business on November 20, 2017 as the record date (the “Record Date”) for determining the shareholders entitled to receive notice of and to vote at the annual general meeting or any adjournment thereof.

 

A shareholder entitled to attend and vote at the meeting is entitled to appoint a proxy to attend and vote in his/her place. A proxy need not be a shareholder of the Company. A form of proxy is attached.

 

To be valid, the form of proxy must be duly completed, signed and delivered, together with the power of attorney or other authority under which it is signed (if any) or a notarially certified copy thereof, to 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China for the attention of director Yang Jianyu no later than the time for holding the meeting or the adjourned meeting at which the proxy is to be used.

 

By the Order of the Board.

 

/s/ Jianyu Yang
Chairman
Date:  11/09/2017

 

 

Exhibit 99.3

 

 

Concord Medical Services Holdings Limited

(the "Company")

 

SHAREHOLDER PROXY

 

 

 

I/We,

of

 

,

 

being the registered holder(s) of

(Note 1) class

(Note 1) ordinary share(s) of the Company, hereby appoint

the Chairman of the Meeting or (Note 2)

of

as my/our proxy to act for me/us at the annual general meeting of the Company to be held at 10:00 a.m. on December 21, 2017 at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China (or at any adjournment thereof) (the “Meeting”) and in particular (but without limitation) at such Meeting (or at any adjournment thereof) to vote for me/us in my/our name(s) as indicated below (or if no such indication is given as my/our proxy thinks fit) and on any other resolutions which may properly come before the Meeting as my/our proxy thinks fit and to do all acts and things which I/ we could personally have done at the Meeting in such manner as my/our proxy thinks fit and if expedient to demand a poll. 

 

Please indicate with a √ in the spaces provided how you wish your vote(s) to be cast. Should this proxy form be returned duly signed, but without a specific direction, the proxy will vote at his discretion.

 

 

	FOR	AGAINST	ABSTAIN
Ordinary Resolution 1	¨	¨	¨
"THAT the appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ended December 31, 2016 at a fee agreed by the directors be and is hereby ratified, confirmed and approved in all respects."
Ordinary Resolution 2	¨	¨	¨
"THAT the appointment of Ernst & Young Hua Ming as independent auditor of the Company for the fiscal year ending December 31, 2017 at a fee agreed by the directors be and is hereby approved."
Ordinary Resolution 3	¨	¨	¨
"THAT the financial statements of fiscal year ended December 31, 2016 contained in the Company’s 2016 annual report be and is hereby ratified, confirmed, approved and adopted in all respects."

 

The proxy may vote as the proxy thinks fit or abstain from voting in respect of any other matters which may properly come before the Meeting.

 

Signed:
Dated:

 

NOTES

 

1.

Please insert the number and class of shares registered in your name(s) to which this proxy relates. If no number or class is inserted, this form of proxy will be deemed to relate to all the shares in the Company registered in your name(s).

 

2.

If any proxy other than the Chairman of the Meeting is preferred, strike out the words “the Chairman of the Meeting or” and insert the name and address of the proxy desired in the space provided. Any alteration made to this form of proxy must be initialled by the person(s) who sign(s) it.

 

3.

A member entitled to attend and vote at the Meeting may appoint a proxy to attend and vote in place of the member.  A proxy need not be a member of the Company.

 

4.

This form of proxy must be signed by the appointor under hand or by his/her attorney duly authorised in writing or, if the appointor is a corporation, either under its common seal or the hand of an officer or attorney duly authorised.

 

5.

If the proxy form is returned without an indication as to how the proxy is to vote on a particular matter, the proxy will exercise the proxy’s discretion as to whether, and how the proxy will vote.

 

6.

Any alterations made to this form must be initialled.

 

To be effective, the proxy form and any authority under which it is executed (or a notarially certified copy of such authority) must be deposited at 18/F, Tower A, Global Trade Center, 36 North 3rd Ring Road East, Dongcheng District, Beijing, P.R. China no later than the time for holding the Meeting or any adjournment thereof.  Completion and return of the proxy form will not prevent shareholders entitled to vote from attending and voting in person at the Meeting and in such event, the proxy shall be deemed to be revoked.